To analyze biochemically the tau aggregation induced by the AD tau fractions, we also lysed the cells with RIPA buffer and analyzed the levels of tau in RIPA-soluble and -insoluble fractions by Western blots developed with anti-HA and a mixture of R134d and 92e. This evidence concerns the gene MAPT and Alzheimer disease.